MAXYMUNE THERAPEUTICS Trademark
Trademark Overview
On Thursday, May 16, 2024, a trademark application was filed for MAXYMUNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MAXYMUNE THERAPEUTICS trademark a serial number of 98554749. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 25, 2025. This trademark is owned by Transplant RX. The MAXYMUNE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of autoimmune diseases
Conducting early evaluations in the field of new pharmaceutical preparations, development of pharmaceutical preparations and medicines, pharmaceutical drug development services, pharmaceutical product evaluation, pharmaceutical product research and development, research on the subject of pharmaceuticals, namely, for the treatment of autoimmune diseases
General Information
| Serial Number | 98554749 |
| Word Mark | MAXYMUNE THERAPEUTICS |
| Filing Date | Thursday, May 16, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, February 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune diseases |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Conducting early evaluations in the field of new pharmaceutical preparations, development of pharmaceutical preparations and medicines, pharmaceutical drug development services, pharmaceutical product evaluation, pharmaceutical product research and development, research on the subject of pharmaceuticals, namely, for the treatment of autoimmune diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 16, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 16, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Transplant RX |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Altos, CA 94022 |
| Party Name | Transplant RX |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Altos, CA 94022 |
Trademark Events
| Event Date | Event Description |
| Thursday, May 16, 2024 | NEW APPLICATION ENTERED |
| Tuesday, November 19, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 2, 2024 | ASSIGNED TO EXAMINER |
| Friday, December 6, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 6, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, December 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 6, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 6, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 31, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 31, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 25, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
